Durable complete response to immunotherapy with anti‐PD‐1 antibody nivolumab in a patient with oral squamous cell carcinoma presenting with lung metastasis: A case report

Although the optimal treatment method for metastatic oral cancer remains largely unknown, the present case suggests that immunotherapy is a potentially promising alternative for metastatic oral cancer in which other therapies are no longer effective.

• Publication year

  2021

• Venue

  Clinical Case Reports

• Publication date

  2021-08-30

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/ccr3.4545PMID 34484745PMCID 8405368
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Durable complete response to immunotherapy with anti‐PD‐1 antibody nivolumab in a patient with oral squamous cell carcinoma presenting with lung metastasis: A case report

  2021cited by this paper
• Biomarkers of cetuximab resistance in patients with head and neck squamous cell carcinoma

  2020cited by this paper
• Biomarkers for Immune Checkpoint Inhibitor-Mediated Tumor Response and Adverse Events

  2019cited by this paper
• Prognostic utility of baseline neutrophil-to-lymphocyte ratio in patients receiving immune checkpoint inhibitors: a review and meta-analysis

  2018cited by this paper
• Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response

  2017cited by this paper
• Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck.

  2016cited by this paper
• Prognostic significance of lymph node density in squamous cell carcinoma of the tongue

  2016cited by this paper
• Nivolumab for recurrent squamous-cell carcinoma of the head and neck

  2016cited by this paper
• Survival After Distant Metastasis in Head and Neck Cancer.

  2015cited by this paper
• Immune checkpoint blockade: a common denominator approach to cancer therapy.

  2015cited by this paper
• Diagnostic modalities for distant metastasis in head and neck squamous cell carcinoma: Are we changing life expectancy?

  2012cited by this paper
• Distant metastases from head and neck squamous cell carcinoma. Part I. Basic aspects.

  2012cited by this paper
• Oral cancer prevention and control--the approach of the World Health Organization.

  2009cited by this paper
• Platinum-based chemotherapy plus cetuximab in head and neck cancer.

  2008cited by this paper
• Pulmonary Resection for Metastatic Head and Neck Cancer

  2008cited by this paper
• Does Surgical Resection of Pulmonary Metastases of Head and Neck Cancer Improve Survival?

  2008cited by this paper
• Perez and Brady's Principles and Practice of Radiation Oncology

  2008cited by this paper
• Squamous cell carcinoma of the buccal mucosa: An aggressive cancer requiring multimodality treatment

  2006cited by this paper
• Prognostic factors and long‐term survivorship in patients with recurrent or metastatic carcinoma of the head and neck

  2004cited by this paper
• Incidence and Sites of Distant Metastases from Head and Neck Cancer

  2001cited by this paper
• Squamous cell carcinoma of the oral soft tissues: a statistical analysis of 14,253 cases by age, sex, and race of patients.

  1976cited by this paper
• Oral Cancer Prevention and Control – the Approach of the World Health Organization

  year unknowncited by this paper

• Durable Response of Short-term Low-dose Nivolumab in a Patient with Locally Advanced Cutaneous Squamous Cell Carcinoma: A Case Report

  2025cites this paper
• Prognostic and clinicopathological significance of prognostic nutritional index (PNI) in patients with oral cancer: a meta-analysis

  2023influential citation
• Pathologic complete response of hepatoid adenocarcinoma of the stomach after chemo-immunotherapy: A rare case report and literature review

  2023cites this paper
• Discontinuation of anti‑programmed cell death protein 1 immune checkpoint inhibition after complete remission in head and neck squamous cell carcinoma: A case report and literature review

  2023cites this paper
• Immunotherapy and Targeted Therapy in the Management of Oral Cancers.

  2022cites this paper
• Durable complete response to immunotherapy with anti‐PD‐1 antibody nivolumab in a patient with oral squamous cell carcinoma presenting with lung metastasis: A case report

  2021cites this paper